Asia Pacific is emerging as a strategic powerhouse in the global bioprocess bags market, propelled by robust investments in biomanufacturing infrastructure and surging demand for biopharmaceuticals. The shift toward single-use systems, personalized medicine, and advanced cell and gene therapies - coupled with high-throughput processing - supports this expansion. As a result, the market is...